Furthermore, analysis of numerous clinicopathological features of BRCA samples in the TCGA showed that ACE2 mRNA expression mainly correlates with gender, histologic subtypes, cancer stages, TP53 mutation status, menopause status, and cancer subclasses (Figure 2). Here, ACE2 is linked to cancer.